NEW TREATMENT OF IMMUNODEFICIENCY DISORDER

The use of montelukast or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of an immunodeficiency disorder and also for the treatment of a disorder characterized by inflammation in a patient that has, or is vulnerable to, a condition characterized by i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: SAMUELSSON, Bengt Ingemar
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The use of montelukast or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of an immunodeficiency disorder and also for the treatment of a disorder characterized by inflammation in a patient that has, or is vulnerable to, a condition characterized by immunosuppression. Particular disorders that may be mentioned include those brought on by radiation therapy as part of e.g. cancer treatment, such as radiation proctitis. Montelukast and salts thereof are preferably administered topically and locally, for example anorectally.